Klivira
Request demo

Streamlining Cigna Ocrevus Prior Authorization Workflows

Navigating Cigna Ocrevus prior authorization requires precise understanding of both medical and pharmacy benefit channels. Klivira streamlines these complex workflows to accelerate patient access.

For revenue cycle directors and prior authorization teams, managing specialty drug PAs like Ocrevus presents significant administrative burden. Efficiently processing these authorizations with Cigna Healthcare and Evernorth is critical for timely patient care and financial health. Klivira provides the automation and connectivity to reduce manual effort and improve approval rates.

Ocrevus Prior Authorization: Cigna Healthcare and Evernorth Channels

Ocrevus, a high-volume specialty drug, typically requires prior authorization under both the medical and pharmacy benefits. For Cigna Healthcare members, this means navigating distinct submission pathways through CignaforHCP for medical claims and Evernorth's Express Scripts or Accredo for pharmacy benefit claims. Klivira integrates directly with these channels to unify the submission process.

Medical Benefit Prior Authorization for Ocrevus with Cigna Healthcare

When Ocrevus is administered in a clinical setting (e.g., infusion center), prior authorization typically falls under Cigna Healthcare's medical benefit. Submissions are directed via the CignaforHCP.com provider portal or through X12 278 transactions via clearinghouses. Klivira automates the assembly and submission of required clinical documentation to these channels, reducing manual data entry and submission errors.

Pharmacy Benefit Prior Authorization for Ocrevus via Evernorth

For Ocrevus dispensed through a pharmacy, prior authorization is managed by Evernorth's pharmacy benefit manager, Express Scripts. This often involves Accredo, the specialty pharmacy under Express Scripts, for specialty injectable medications. Submissions can route through the Express Scripts provider PA system or through ePA partners like CoverMyMeds and Surescripts for prescriber-initiated workflows.

Cigna Healthcare Coverage Policies and Ocrevus Documentation

Cigna Healthcare publishes specific coverage policies and medical necessity guidelines for specialty drugs like Ocrevus on its public provider site. These policies outline clinical indications, step therapy requirements, and site-of-care criteria. Adherence to these versioned policies, including specific policy numbers and effective dates, is critical for authorization approval and avoiding unnecessary denials.

Mitigating Ocrevus Prior Authorization Denials with Cigna

  • Medical necessity not met or insufficient documentation submitted.
  • Failure to meet step therapy or required preceding therapy criteria.
  • Site-of-service mismatch for medical benefit administration.
  • Non-formulary pharmacy denials through Express Scripts.
  • Benefit exclusion or member eligibility issues.
  • Incomplete or inaccurate clinical information provided.

Electronic Prior Authorization and Turnaround Expectations

Klivira leverages established electronic prior authorization (ePA) capabilities where available, including Express Scripts' integrations with CoverMyMeds and Surescripts. For Cigna Healthcare's medical benefit, Klivira supports efficient X12 278 submissions. Turnaround times are governed by state-specific regulations and, for Medicare Advantage plans, by CMS-0057-F phased compliance timelines, requiring rapid processing.

Frequently asked questions

Which Cigna entity handles Ocrevus prior authorizations?

Prior authorizations for Ocrevus are managed by Cigna Healthcare for the medical benefit, typically through CignaforHCP.com, and by Evernorth's Express Scripts, often involving Accredo, for the pharmacy benefit.

What are the primary submission channels for Ocrevus PA with Cigna?

For medical benefit Ocrevus, submissions are via CignaforHCP.com or X12 278. For pharmacy benefit, channels include Express Scripts' provider PA system and ePA partners like CoverMyMeds and Surescripts.

How does Klivira help with Cigna Ocrevus prior authorization?

Klivira automates the submission process by integrating with CignaforHCP, Express Scripts, and ePA platforms, centralizing documentation, and tracking status updates across both medical and pharmacy benefits for Ocrevus.

Where can I find Cigna's coverage policies for Ocrevus?

Cigna Healthcare publishes its medical necessity guidelines and coverage policies on its public provider site. Consult these resources for specific Ocrevus criteria, policy numbers, and effective dates.

Are there specific denial reasons common for Ocrevus with Cigna?

Common denial reasons include insufficient documentation, failure to meet step therapy, site-of-service issues, and non-formulary pharmacy denials. Klivira helps address these by ensuring complete and accurate submissions aligned with Cigna's policies.

Does Cigna support electronic prior authorization (ePA) for Ocrevus?

Yes, Express Scripts, as Evernorth's PBM, has established ePA capabilities through CoverMyMeds and Surescripts for pharmacy benefit drugs like Ocrevus. Klivira leverages these existing ePA pathways for efficiency.

Related coverage

Other ocrevus prior authorization by payer

Other ocrevus prior authorization by specialty

Ready to automate prior auth for this drug?

See how Klivira automates prior authorizations for your team.

Request a demo